(Q43985706)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999623%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

title

Visual field constriction and electrophysiological changes associated with vigabatrin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999623%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999623%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Eberhart Zrenner

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999623%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1

Dorothea Besch

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999623%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Eckart Apfelstedt-Sylla

3

object named as

Eckart Apfelstedt-Sylla

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999623%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

Bettina Sadowski

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999623%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Dieter Dennig

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999623%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Christiane Asenbauer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999623%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Ulrich Schiefer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999623%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

publication date

1 March 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999623%20AND%20SRC:MED&resulttype=core&format=json

Documenta Ophthalmologica

10 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999623%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999623%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999623%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

151-170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11999623%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1014644307518

10 December 2019

exact match

0 references

cites work

No effect of long-term vigabatrin treatment on central nervous system conduction in patients with refractory epilepsy: results of a multicenter study of somatosensory and visual evoked potentials. PMS Study Multicenter Group

1 reference

12 December 2020

The eclectroretinogram: its components and their origins

1 reference

12 December 2020

Symptomatic and asymptomatic visual loss in patients taking vigabatrin.

1 reference

12 December 2020

A double-blind, placebo-controlled study of vigabatrin three g/day in patients with uncontrolled complex partial seizures. Vigabatrin Protocol 024 Investigative Cohort

1 reference

12 December 2020

Characteristics of a unique visual field defect attributed to vigabatrin

1 reference

12 December 2020

Severe persistent visual field constriction associated with vigabatrin

1 reference

12 December 2020

Study is needed of visual field defects associated with any long term antiepileptic drug

1 reference

12 December 2020

Immunocytochemical evidence that vigabatrin in rats causes GABA accumulation in glial cells of the retina

1 reference

12 December 2020

Visual field constriction in children treated with vigabatrin

1 reference

12 December 2020

Disorders of color perception and increase glare sensitivity in phenytoin and carbamazepine therapy. Ocular side effects of anticonvulsants

1 reference

12 December 2020

Severe visual-field constriction and side-effects of GABA-mimetic antiepileptic agents

1 reference

12 December 2020

Severe persistent visual field constriction associated with vigabatrin. Patients taking vigabatrin should have regular visual field testing.

1 reference

12 December 2020

Visual field defects associated with vigabatrin therapy

1 reference

12 December 2020

Vigabatrin-induced optic neuropathy

1 reference

12 December 2020

Visual dysfunction in patients receiving vigabatrin: clinical and electrophysiologic findings

1 reference

12 December 2020

Outer retinal dysfunction in patients treated with vigabatrin

1 reference

12 December 2020

Rod and cone system contributions to oscillatory potentials: an explanation for the conditioning flash effect

1 reference

12 December 2020

Severe persistent visual field constriction associated with vigabatrin. Reaction might be dose dependent

1 reference

12 December 2020

Severe persistent visual field constriction associated with vigabatrin. Benefit: risk ratio must be calculated for individual patients

1 reference

12 December 2020

Reversibility of vigabratin-induced visual-field defect

1 reference

12 December 2020

A study of the effects of vigabatrin on the central nervous system and retina of Sprague Dawley and Lister-Hooded rats

1 reference

12 December 2020

Severe persistent visual field constriction associated with vigabatrin. Chronic refractory epilepsy may have role in causing these unusual lesions

1 reference

12 December 2020

Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin

1 reference

12 December 2020

Standard for clinical electroretinography (1999 update). International Society for Clinical Electrophysiology of Vision.

1 reference

12 December 2020

A topographic study of oscillatory potentials in man

1 reference

12 December 2020

Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects

1 reference

12 December 2020

Visual electrophysiological effect of a GABA transaminase blocker

1 reference

12 December 2020

GABA transamination regulates neuronal glutamate content in the retina.

1 reference

12 December 2020

MRI findings in epileptic patients on vigabatrin for more than 5 years.

1 reference

12 December 2020

The field topography of ERG components in man—I. The photopic luminance response

1 reference

12 December 2020

Standard for clinical electro-oculography. International Society for Clinical Electrophysiology of Vision.

1 reference

12 December 2020

Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings.

1 reference

12 December 2020

Chronic toxicity studies with vigabatrin, a GABA-transaminase inhibitor

1 reference

12 December 2020

Severe persistent visual field constriction associated with vigabatrin. Manufacturers have started several studies

1 reference

12 December 2020

Severe persistent visual field constriction associated with vigabatrin. Asymptomatic as well as symptomatic defects occur with vigabatrin

1 reference

12 December 2020

Severe persistent visual field constriction associated with vigabatrin. Four possible explanations exist.

1 reference

12 December 2020